Y, L., L, S., DS, B., & KD, G. (2022). Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review. JACC. CardioOncology, 4(3), 287. https://doi.org/10.1016/j.jaccao.2022.08.002
Chicago Style (17th ed.) CitationY, Li, Sun L, Burstein DS, and Getz KD. "Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review." JACC. CardioOncology 4, no. 3 (2022): 287. https://doi.org/10.1016/j.jaccao.2022.08.002.
MLA (9th ed.) CitationY, Li, et al. "Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review." JACC. CardioOncology, vol. 4, no. 3, 2022, p. 287, https://doi.org/10.1016/j.jaccao.2022.08.002.